Copyright
©The Author(s) 2023.
World J Clin Cases. Oct 26, 2023; 11(30): 7284-7293
Published online Oct 26, 2023. doi: 10.12998/wjcc.v11.i30.7284
Published online Oct 26, 2023. doi: 10.12998/wjcc.v11.i30.7284
Figure 1 Comparison of forkhead box M1, cyclooxygenase-2, and glucose-regulated protein 78 expression levels between the two groups.
A: Forkhead box M1 expression levels; B: Cyclooxygenase-2 expression levels; C: Glucose-regulated protein 78 expression levels. aP < 0.05. FOXM1: Forkhead box M1; COX-2: Cyclooxygenase-2; GRP78: Glucose-regulated protein 78.
Figure 2 Diagnostic value of forkhead box M1, cyclooxygenase-2, and glucose-regulated protein 78 in breast infiltrating ductal carcinoma.
A: Forkhead box M1; B: Cyclooxygenase-2; C: Glucose-regulated protein 78. AUC: Area under the curve; CI: Confidence interval.
Figure 3 Relationship between expression levels of forkhead box M1, cyclooxygenase-2, and glucose-regulated protein 78 in breast infiltrating ductal carcinoma.
A: Correlation between forkhead box M1 (FOXM1) and cyclooxygenase-2 (COX-2) mRNA expression; B: Correlation between FOXM1 and glucose-regulated protein 78 (GRP78) mRNA expression; C: Correlation between COX-2 and GRP78 mRNA expression. FOXM1: Forkhead box M1; COX-2: Cyclooxygenase-2; GRP78: Glucose-regulated protein 78.
- Citation: Bai J, Li Y, Cai L. Clinical implications of forkhead box M1, cyclooxygenase-2, and glucose-regulated protein 78 in breast invasive ductal carcinoma. World J Clin Cases 2023; 11(30): 7284-7293
- URL: https://www.wjgnet.com/2307-8960/full/v11/i30/7284.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i30.7284